VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 374 filers reported holding VANECK VECTORS ETF TR in Q2 2017. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,917,015 | -0.8% | 71,238 | +11.1% | 0.18% | +0.6% |
| Q2 2023 | $1,931,527 | +79.2% | 64,149 | +92.5% | 0.17% | +91.2% |
| Q1 2023 | $1,078,064 | +115.3% | 33,325 | +90.7% | 0.09% | +89.6% |
| Q4 2022 | $500,834 | +72.1% | 17,475 | +44.7% | 0.05% | +37.1% |
| Q3 2022 | $291,000 | +7.8% | 12,075 | +71.5% | 0.04% | +25.0% |
| Q1 2022 | $270,000 | +13400.0% | 7,040 | +6940.0% | 0.03% | – |
| Q3 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -60.0% | 100 | -50.0% | 0.00% | -100.0% |
| Q3 2017 | $5,000 | +150.0% | 200 | +100.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |